Sanofi said the GEMINI 1 and 2 trials of tolebrutinib in relapsing forms of MS are fully enrolled and should read out in time to meet its plan of filing for regulatory approval in the US in 2024.

Ukraine has reportedly agreed on the terms of a major minerals deal with the US, and President Trump said he was expecting his Ukrainian counterpart Volodymyr Zelensky in Washington to sign the deal ...

A petition with over 250,000 signatures is calling for the revocation of Elon Musk's Canadian citizenship. The billionaire is accused of undermining Canada's sovereignty and supporting US ...

GB News host Patrick Christys discusses how President Donald Trump is “using leverage” to “get what he wants” when it comes to foreign… ...